Antigenic structure of chimeras of type 1 and type 3 poliovirus involving antigenic site 1

References

1. Baehr W., Zhang Y.-X., Joseph T., Su H., Nano F. E., Everett K. D. E., Caldwell H. 1988; Mapping protective antigenic domains expressed by C. trachomatis major outer membrane protein genes. Proceedings of the National Academy of Sciences, U.S.A 85:4000–4004
   [Google Scholar]
2. Blondel B., Crainic R., Fichet O., Dufraisse G., Candrea A., Diamond D., Girard M., Horaud F. 1986; Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody binding site. Journal of Virology 57:81–90
   [Google Scholar]
3. Burke K. L., Dunn G., Ferguson M., Minor P. D., Almond J. W. 1988; Antigen chimeras of poliovirus as potential new vaccines. Nature; London: 33281–82
   [Google Scholar]
4. Burke K. L., Evans D. J., Jenkins O., Meredith J., D’Souza E. D. A., Almond J. W. 1989; A cassette vector for the construction of antigen chimaeras of poliovirus. Journal of General Virology 70:2475–2479
   [Google Scholar]
5. Colbere-Garapin F., Christodoulous C., Crainic R., Garapin A.-C., Candrea A. 1988; Addition of a foreign epitope to the major capsid protein of poliovirus oligopeptide. Proceedings of the National Academy of Sciences, U.S.A 85:8668–8672
   [Google Scholar]
6. Diamond D. C., Jameson B. A., Bonin J., Kohara M., Abe S., Itoh H., Komatsu T., Arita M., Kuge S., Nomoto A., Osterhaus A. D. M. E., Crainic R., Wimmer E. 1985; Antigenic variation and resistance to neutralization in poliovirus type 1. Science 229:1090–1093
   [Google Scholar]
7. Domok I., Magrath D. I. 1979; Guide to poliovirus isolation and serological techniques for poliomyelitis surveillance. WHO Offset Publication46
   [Google Scholar]
8. Evans D. J., Mckeating J., Meredith J. M., Burke K. L., Katrak K., John A., Ferguson M., Minor P. D., Weiss R. A., Almond J. W. 1989; An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies. Nature; London: 339385–388
   [Google Scholar]
9. Ferguson M., Minor P. D., Magrath D. I., Qi Y.-H., Spitz M., Schild G. C. 1984; Neutralization epitopes on poliovirus type 3 particles: an analysis using monoclonal antibodies. Journal of General Virology 65:197–201
   [Google Scholar]
10. Ferguson M., Evans D. M. A., Magrath D. I., Minor P. D., Almond J. W., Schild G. C. 1985; Induction by synthetic peptides of broadly reactive, type specific neutralizing antibody to poliovirus type 3. Virology 143:505–515
    [Google Scholar]
11. Ferguson M., Reed S. E., Minor P. D. 1986; Reactivity of antipeptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptides. Journal of General Virology 67:2527–2531
    [Google Scholar]
12. Filman D. J., Syed R., Chow M., Macadam A. J., Minor P. D., Hogle J. M. 1989; Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO Journal 8:1567–1579
    [Google Scholar]
13. Hogle J. M., Chow M., Filman D. J. 1985; Three dimensional structure of poliovirus at 2·9 Å resolution. Science 229:1358–1365
    [Google Scholar]
14. Jenkins O., Cason J., Burke K. L., Lunney D., Gillen A., Patel D., Mccance D. J., Almond J. W. 1990; An antigen chimera of poliovirus induces antibodies against human papillomavirus type 16. Journal of Virology 64:1201–1206
    [Google Scholar]
15. Martin A., Wychowski C., Couderc T., Crainic K., Hogle J., Girard M. 1988; Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO Journal 7:2839–2847
    [Google Scholar]
16. Minor P. D., Schild G. C., Bootman J., Evans D. M. A., Ferguson M., Reeve P., Spitz M., Stanway F., Cann A. J., Hauptmann R., Clarke L. D., Mountford R. C., Almond J. W. 1983; Location and primary structure of a major antigenic site for poliovirus neutralization. Nature; London: 301674–679
    [Google Scholar]
17. Minor P. D., Pipkin P., Hockley D., Schild G. C., Almond J. W. 1984; Monoclonal antibodies which block cellular receptors of poliovirus. Virus Research 1:203–212
    [Google Scholar]
18. Minor P. D., Evans D. M. A., Ferguson M., Schild G. C., Westrop G., Almond J. W. 1985; Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3. Journal of General Virology 66:1159–1165
    [Google Scholar]
19. Minor P. D., Ferguson M., Evans D. M. A., Almond J. W., Icenogle J. P. 1986; Antigenic structure of polioviruses of serotypes 1, 2 and 3. Journal of General Virology 67:1283–1291
    [Google Scholar]
20. Minor P. D., Ferguson M., Phillips A., Magrath D. I., Huovilainen A., Hovi T. 1987; Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus. Journal of General Virology 68:1857–1865
    [Google Scholar]
21. Mosser A., Rueckert R. R. 1987; Abstracts of the VII Congress of Virology, OP 8.4.
    [Google Scholar]
22. Murdin A. D., Wimmer E. 1989; Construction of a poliovirus type 1/type 2 antigenic hybrid by manipulation of neutralization antigenic site II. Journal of Virology 63:5251–5257
    [Google Scholar]
23. Murray M. G., Kuhn R. J., Arita M., Kawamura N., Nomoto A., Wimmer E. 1988a; Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proceedings of the National Academy of Sciences, U.S.A 85:3203–3207
    [Google Scholar]
24. Murray M. G., Bradley J., Yang X-F., Wimmer E., Moss E. G., Racaniello V. R. 1988b; Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site 1. Science 241:213–215
    [Google Scholar]
25. Page G. S., Mosser A. G., Hogle J. M., Filman D. J., Rueckert R. R., Chow M. 1988; Three dimensional structure of poliovirus serotype 1 neutralizing determinants. Journal of Virology 62:1781–1794
    [Google Scholar]
26. Stanway G., Hughes P. J., Westrop G. D., Evans D. M. A., Dunn G., Minor P. D., Schild G. C., Almond J. W. 1986; Construction of poliovirus intertypic recombinants by use of cDNA. Journal of Virology 57:1187–1190
    [Google Scholar]
27. Wiegers K., Uhlig H., Dernick R. 1989; N-AglB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152. Virology 70:583–586
    [Google Scholar]